Hank F. Kung - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Pharmacology, Organic Chemistry, Pharmaceutical Chemistry

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Qiao H, Zhang Y, Wu Z, Zhu L, Choi SR, Ploessl K, Kung HF. One-step preparation of [(18)F]FPBM for PET imaging of serotonin transporter (SERT) in the brain. Nuclear Medicine and Biology. 43: 470-477. PMID 27236282 DOI: 10.1016/j.nucmedbio.2016.04.003  0.48
2016 Wu Z, Zha Z, Choi SR, Plössl K, Zhu L, Kung HF. New 68Ga-PhenA bisphosphonates as potential bone imaging agents Nuclear Medicine and Biology. 43: 360-371. DOI: 10.1016/j.nucmedbio.2016.03.002  0.48
2014 Graham TJ, Lambert RF, Ploessl K, Kung HF, Doyle AG. Enantioselective radiosynthesis of positron emission tomography (PET) tracers containing [¹⁸F]fluorohydrins. Journal of the American Chemical Society. 136: 5291-4. PMID 24628021 DOI: 10.1021/ja5025645  0.48
2014 Wang L, Lieberman BP, Ploessl K, Kung HF. Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging. Nuclear Medicine and Biology. 41: 58-67. PMID 24183614 DOI: 10.1016/j.nucmedbio.2013.09.011  0.48
2014 Liu Y, Yue F, Tang R, Tao G, Pan X, Zhu L, Kung HF, Chan P. Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133). Neuroscience Bulletin. 30: 409-16. PMID 24061965 DOI: 10.1007/s12264-013-1374-3  0.48
2013 Zhu L, Ploessl K, Kung HF. Chemistry. Expanding the scope of fluorine tags for PET imaging. Science (New York, N.Y.). 342: 429-30. PMID 24159034 DOI: 10.1126/science.1245011  0.48
2013 Zhu L, Li G, Choi SR, Plössl K, Chan P, Qiao H, Zha Z, Kung HF. An improved preparation of [18F]FPBM: a potential serotonin transporter (SERT) imaging agent. Nuclear Medicine and Biology. 40: 974-9. PMID 24035549 DOI: 10.1016/j.nucmedbio.2013.08.002  0.48
2013 Lemoine L, Lieberman BP, Ploessl K, Zheng P, Kung HF. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent. Nuclear Medicine and Biology. 40: 879-86. PMID 23856117 DOI: 10.1016/j.nucmedbio.2013.06.001  0.48
2013 Zheng P, Lieberman BP, Ploessl K, Lemoine L, Miller S, Kung HF. A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol. Bioorganic & Medicinal Chemistry Letters. 23: 869-72. PMID 23265880 DOI: 10.1016/j.bmcl.2012.11.043  0.48
2012 Kung HF. The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing. Acs Medicinal Chemistry Letters. 3: 265-7. PMID 24936237 DOI: 10.1021/ml300058m  0.48
2012 Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1616-24. PMID 22935578 DOI: 10.2967/jnumed.111.101279  0.48
2012 Zhu L, Qiao H, Lieberman BP, Wu J, Liu Y, Pan Z, Ploessl K, Choi SR, Chan P, Kung HF. Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier. Nuclear Medicine and Biology. 39: 897-904. PMID 22749185 DOI: 10.1016/j.nucmedbio.2012.05.002  0.48
2012 Qiao H, Zhu L, Lieberman BP, Zha Z, Plössl K, Kung HF. Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 22: 4303-6. PMID 22658558 DOI: 10.1016/j.bmcl.2012.05.030  0.48
2012 Cooper AJ, Krasnikov BF, Pinto JT, Kung HF, Li J, Ploessl K. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 163: 108-20. PMID 22613816 DOI: 10.1016/j.cbpb.2012.05.010  0.48
2012 Wang L, Zha Z, Qu W, Qiao H, Lieberman BP, Plössl K, Kung HF. Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents. Nuclear Medicine and Biology. 39: 933-43. PMID 22542392 DOI: 10.1016/j.nucmedbio.2012.03.007  0.48
2012 Choi SR, Schneider JA, Bennett DA, Beach TG, Bedell BJ, Zehntner SP, Krautkramer MJ, Kung HF, Skovronsky DM, Hefti F, Clark CM. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Disease and Associated Disorders. 26: 8-16. PMID 22354138 DOI: 10.1097/WAD.0b013e31821300bc  0.48
2012 Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neuro-Degenerative Diseases. 10: 161-5. PMID 22261520 DOI: 10.1159/000334535  0.48
2012 Qu W, Oya S, Lieberman BP, Ploessl K, Wang L, Wise DR, Divgi CR, Chodosh LA, Chodosh LP, Thompson CB, Kung HF. Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 98-105. PMID 22173839 DOI: 10.2967/jnumed.111.093831  0.48
2011 Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proceedings of the National Academy of Sciences of the United States of America. 108: 20719-24. PMID 22143775 DOI: 10.1073/pnas.1109480108  0.48
2011 Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, Chodosh LA, Belka G, Thompson CB, Kung HF. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1947-55. PMID 22095958 DOI: 10.2967/jnumed.111.093815  0.48
2011 Carberry P, Carpenter AP, Kung HF. Fluoride-18 radiolabeling of peptides bearing an aminooxy functional group to a prosthetic ligand via an oxime bond. Bioorganic & Medicinal Chemistry Letters. 21: 6992-5. PMID 22024031 DOI: 10.1016/j.bmcl.2011.09.124  0.48
2011 Zha Z, Choi SR, Ploessl K, Lieberman BP, Qu W, Hefti F, Mintun M, Skovronsky D, Kung HF. Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). Journal of Medicinal Chemistry. 54: 8085-98. PMID 22011144 DOI: 10.1021/jm2009106  0.48
2011 Zhou X, Qiao J, Yin W, Zhu L, Kung HF. Determination of the penetration of 9-fluoropropyl-(+)-dihydrotetrabenazine across the blood-brain barrier in rats by microdialysis combined with liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 879: 3041-6. PMID 21937290 DOI: 10.1016/j.jchromb.2011.08.043  0.48
2011 Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, Ackermann U, O'Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. Archives of Neurology. 68: 905-12. PMID 21747030 DOI: 10.1001/archneurol.2011.142  0.48
2011 Qu W, Zha Z, Lieberman BP, Mancuso A, Stetz M, Rizzi R, Ploessl K, Wise D, Thompson C, Kung HF. Facile Synthesis [5- 13C-4- 2H 2]-L-Glutamine for Hyperpolarized MRS Imaging of Cancer Cell Metabolism Academic Radiology. 18: 932-939. PMID 21658976 DOI: 10.1016/j.acra.2011.05.002  0.48
2011 Lister-James J, Pontecorvo MJ, Clark C, Joshi AD, Mintun MA, Zhang W, Lim N, Zhuang Z, Golding G, Choi SR, Benedum TE, Kennedy P, Hefti F, Carpenter AP, Kung HF, et al. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. Seminars in Nuclear Medicine. 41: 300-4. PMID 21624563 DOI: 10.1053/j.semnuclmed.2011.03.001  0.48
2011 Zheng P, Lieberman BP, Choi SR, Plöessl K, Kung HF. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands. Bioorganic & Medicinal Chemistry Letters. 21: 3435-8. PMID 21531556 DOI: 10.1016/j.bmcl.2011.03.113  0.48
2011 Zha Z, Zhu L, Liu Y, Du F, Gan H, Qiao J, Kung HF. Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging. Nuclear Medicine and Biology. 38: 501-8. PMID 21531287 DOI: 10.1016/j.nucmedbio.2010.11.001  0.48
2011 Wang L, Lieberman BP, Plössl K, Qu W, Kung HF. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents. Nuclear Medicine and Biology. 38: 301-12. PMID 21492778 DOI: 10.1016/j.nucmedbio.2010.10.004  0.48
2011 Liu J, Zhu L, Plössl K, Lieberman BP, Kung HF. Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters. 21: 2962-5. PMID 21458259 DOI: 10.1016/j.bmcl.2011.03.051  0.48
2011 Carberry P, Lieberman BP, Ploessl K, Choi SR, Haase DN, Kung HF. New F-18 prosthetic group via oxime coupling. Bioconjugate Chemistry. 22: 642-53. PMID 21452846 DOI: 10.1021/bc1004262  0.48
2011 Zhou X, Qiao J, Yin W, Zhu L, Kung HF. Study the effect of a pseudo-carrier on pharmacokinetics of 9-fluoropropyl-(+)-dihydrotetrabenazine in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 879: 505-10. PMID 21277842 DOI: 10.1016/j.jchromb.2011.01.011  0.48
2011 Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. Jama. 305: 275-83. PMID 21245183 DOI: 10.1001/jama.2010.2008  0.48
2011 Wang L, Qu W, Lieberman BP, Plössl K, Kung HF. Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents. Nuclear Medicine and Biology. 38: 53-62. PMID 21220129 DOI: 10.1016/j.nucmedbio.2010.07.005  0.48
2011 Qu W, Zha Z, Ploessl K, Lieberman BP, Zhu L, Wise DR, Thompson CB, Kung HF. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. Journal of the American Chemical Society. 133: 1122-33. PMID 21190335 DOI: 10.1021/ja109203d  0.48
2010 Liu Y, Zhu L, Plössl K, Choi SR, Qiao H, Sun X, Li S, Zha Z, Kung HF. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease. Nuclear Medicine and Biology. 37: 917-25. PMID 21055622 DOI: 10.1016/j.nucmedbio.2010.05.001  0.48
2010 Wang JL, Deutsch EC, Oya S, Kung HF. FlipADAM: a potential new SPECT imaging agent for the serotonin transporter. Nuclear Medicine and Biology. 37: 577-86. PMID 20610162 DOI: 10.1016/j.nucmedbio.2010.02.010  0.48
2010 Tu Z, Xu J, Jones LA, Li S, Zeng D, Kung MP, Kung HF, Mach RH. Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 68: 2268-73. PMID 20594864 DOI: 10.1016/j.apradiso.2010.06.004  0.48
2010 Wang L, Qu W, Lieberman B, Ploessl K, Kung HF. Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents. Bioorganic & Medicinal Chemistry Letters. 20: 3482-5. PMID 20529679 DOI: 10.1016/j.bmcl.2010.05.007  0.48
2010 Zhu X, Li DP, Fan WG, Lin MC, Wang JL, Lin SQ, Huang JQ, Kung HF. Lack of association between the GRP78 polymorphisms in the promoter and 3' UTR and susceptibility to chronic HBV infection in a Chinese Han population. Bmc Medical Genetics. 11: 83. PMID 20525207 DOI: 10.1186/1471-2350-11-83  0.48
2010 Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 913-20. PMID 20501908 DOI: 10.2967/jnumed.109.069088  0.48
2010 Wang JL, Oya S, Parhi AK, Lieberman BP, Ploessl K, Hou C, Kung HF. In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. Nuclear Medicine and Biology. 37: 479-86. PMID 20447560 DOI: 10.1016/j.nucmedbio.2010.01.006  0.48
2010 Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, Chalon S, Garreau L, Kung HF, Lantier F, Vergote J. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 576-82. PMID 20376566 DOI: 10.1007/s11307-010-0321-1  0.48
2010 Zhu L, Liu Y, Plössl K, Lieberman B, Liu J, Kung HF. An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2. Nuclear Medicine and Biology. 37: 133-41. PMID 20152712 DOI: 10.1016/j.nucmedbio.2009.10.005  0.48
2010 Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 223-8. PMID 20080893 DOI: 10.2967/jnumed.109.070094  0.48
2010 Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer's disease: A miniperspective Journal of Medicinal Chemistry. 53: 933-941. PMID 19845387 DOI: 10.1021/jm901039z  0.48
2009 Serdons K, Van Laere K, Janssen P, Kung HF, Bormans G, Verbruggen A. Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents. Journal of Medicinal Chemistry. 52: 7090-102. PMID 19877643 DOI: 10.1021/jm900871v  0.48
2009 Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1887-94. PMID 19837759 DOI: 10.2967/jnumed.109.065284  0.48
2009 Wang JL, Parhi AK, Oya S, Lieberman B, Kung HF. In vivo characterization of a series of 18F-diaryl sulfides (18F-2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)phenylthio)benzenamine) for PET imaging of the serotonin transporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1509-17. PMID 19690040 DOI: 10.2967/jnumed.108.060723  0.48
2009 Qiao H, Surti S, Choi SR, Raju K, Zhang H, Ponde DE, Kung HF, Karp J, Zhou R. Death and proliferation time course of stem cells transplanted in the myocardium. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 408-14. PMID 19459013 DOI: 10.1007/s11307-009-0222-3  0.48
2009 Wey SP, Weng CC, Lin KJ, Yao CH, Yen TC, Kung HF, Skovronsky D, Kung MP. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques. Nuclear Medicine and Biology. 36: 411-7. PMID 19423009 DOI: 10.1016/j.nucmedbio.2009.01.013  0.48
2009 Scott PJ, Hockley BG, Kung HF, Manchanda R, Zhang W, Kilbourn MR. Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: 88-94. PMID 18951032 DOI: 10.1016/j.apradiso.2008.08.015  0.48
2008 Parhi AK, Kung MP, Ploessl K, Kung HF. Synthesis of Fluorescent Probes based on Stilbenes and Diphenylacetylenes targeting β-Amyloid Plaques. Tetrahedron Letters. 49: 3395-3399. PMID 19122762 DOI: 10.1016/j.tetlet.2008.03.130  0.48
2008 Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nuclear Medicine and Biology. 35: 825-37. PMID 19026944 DOI: 10.1016/j.nucmedbio.2008.08.004  0.48
2008 Qu W, Choi SR, Hou C, Zhuang Z, Oya S, Zhang W, Kung MP, Manchandra R, Skovronsky DM, Kung HF. Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 18: 4823-7. PMID 18707879 DOI: 10.1016/j.bmcl.2008.07.077  0.48
2008 Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF. In vivo imaging of β-cell mass in rats using 18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus Journal of Nuclear Medicine. 49: 1171-1176. PMID 18552132 DOI: 10.2967/jnumed.108.051680  0.48
2008 Wang JL, Parhi AK, Oya S, Lieberman B, Kung MP, Kung HF. 2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters. Nuclear Medicine and Biology. 35: 447-58. PMID 18482682 DOI: 10.1016/j.nucmedbio.2008.02.009  0.48
2008 Stephenson KA, Reid LC, Zubieta J, Babich JW, Kung MP, Kung HF, Valliant JF. Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides. Bioconjugate Chemistry. 19: 1087-94. PMID 18407681 DOI: 10.1021/bc800001g  0.48
2008 Lakshmi B, Kung MP, Lieberman B, Zhao J, Waterhouse R, Kung HF. (R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters. Nuclear Medicine and Biology. 35: 43-52. PMID 18158942 DOI: 10.1016/j.nucmedbio.2007.08.007  0.48
2008 Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, Kung HF, Lam KS, Oddo S, Laferla FM, Jin LW. Congo red and thioflavin-T analogs detect Abeta oligomers. Journal of Neurochemistry. 104: 457-68. PMID 17953662 DOI: 10.1111/j.1471-4159.2007.04972.x  0.48
2007 Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF. 2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents. Journal of Medicinal Chemistry. 50: 6673-84. PMID 18052090 DOI: 10.1021/jm070685e  0.48
2007 Zeng C, Vangveravong S, Xu J, Chang KC, Hotchkiss RS, Wheeler KT, Shen D, Zhuang ZP, Kung HF, Mach RH. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Research. 67: 6708-16. PMID 17638881 DOI: 10.1158/0008-5472.CAN-06-3803  0.48
2007 Qu W, Kung MP, Hou C, Oya S, Kung HF. Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease. Journal of Medicinal Chemistry. 50: 3380-7. PMID 17569520 DOI: 10.1021/jm070467l  0.48
2007 Chandra R, Oya S, Kung MP, Hou C, Jin LW, Kung HF. New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques. Journal of Medicinal Chemistry. 50: 2415-23. PMID 17447752 DOI: 10.1021/jm070090j  0.48
2007 Qu W, Kung MP, Hou C, Benedum TE, Kung HF. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. Journal of Medicinal Chemistry. 50: 2157-65. PMID 17411026 DOI: 10.1021/jm070025+  0.48
2007 Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters Nuclear Medicine and Biology. 34: 239-246. PMID 17383573 DOI: 10.1016/j.nucmedbio.2006.12.005  0.48
2007 Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF. Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain Nuclear Medicine and Biology. 34: 233-237. PMID 17383572 DOI: 10.1016/j.nucmedbio.2007.01.007  0.48
2007 Oya S, Choi SR, Kung MP, Kung HF. 5-Chloro-2-(2'-((dimethylamino)methyl)-4'-iodophenylthio)benzenamine: a new serotonin transporter ligand. Nuclear Medicine and Biology. 34: 129-39. PMID 17307121 DOI: 10.1016/j.nucmedbio.2006.12.002  0.48
2007 Stephenson KA, Chandra R, Zhuang ZP, Hou C, Oya S, Kung MP, Kung HF. Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates. Bioconjugate Chemistry. 18: 238-46. PMID 17226978 DOI: 10.1021/bc060239q  0.48
2007 Zhang W, Kung MP, Oya S, Hou C, Kung HF. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Nuclear Medicine and Biology. 34: 89-97. PMID 17210465 DOI: 10.1016/j.nucmedbio.2006.10.003  0.48
2006 Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters Nuclear Medicine and Biology. 33: 685-694. PMID 16934687 DOI: 10.1016/j.nucmedbio.2006.05.006  0.48
2006 Newberg AB, Wintering NA, Plössl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF. Safety, biodistribution, and dosimetry of 123I-IMPY: A novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease Journal of Nuclear Medicine. 47: 748-754. PMID 16644743  0.48
2006 Zhuang ZP, Kung MP, Kung HF. Synthesis of biphenyltrienes as probes for beta-amyloid plaques. Journal of Medicinal Chemistry. 49: 2841-4. PMID 16640346 DOI: 10.1021/jm051020k  0.48
2006 Chandra R, Kung MP, Kung HF. Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging. Bioorganic & Medicinal Chemistry Letters. 16: 1350-2. PMID 16325402 DOI: 10.1016/j.bmcl.2005.11.055  0.48
2005 Li Z, Qiao H, Lebherz C, Choi SR, Zhou X, Gao G, Kung HF, Rader DJ, Wilson JM, Glickson JD, Zhou R. Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer. Human Gene Therapy. 16: 1429-38. PMID 16390274 DOI: 10.1089/hum.2005.16.1429  0.48
2005 Zhang W, Oya S, Kung MP, Hou C, Maier DL, Kung HF. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nuclear Medicine and Biology. 32: 799-809. PMID 16253804 DOI: 10.1016/j.nucmedbio.2005.06.001  0.48
2005 Kung MP, Kung HF. Mass effect of injected dose in small rodent imaging by SPECT and PET. Nuclear Medicine and Biology. 32: 673-8. PMID 16243641 DOI: 10.1016/j.nucmedbio.2005.04.002  0.48
2005 Zhang W, Oya S, Kung MP, Hou C, Maier DL, Kung HF. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain. Journal of Medicinal Chemistry. 48: 5980-8. PMID 16162001 DOI: 10.1021/jm050166g  0.48
2005 Andrews CM, Kung HF, Lucki I. The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. European Journal of Pharmacology. 508: 123-30. PMID 15680262 DOI: 10.1016/j.ejphar.2004.12.033  0.48
2004 Kung MP, Hou C, Zhuang ZP, Skovronsky D, Kung HF. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease Brain Research. 1025: 98-105. PMID 15464749 DOI: 10.1016/j.brainres.2004.08.004  0.48
2004 Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP. 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: An improved serotonin transporter imaging agent Journal of Medicinal Chemistry. 47: 5258-5264. PMID 15456270 DOI: 10.1021/jm049917p  0.48
Show low-probability matches.